Additionally, METTL3 facilitates immune escape in non-alcoholic fatty liver disease-associated HCC (NAFLD-HCC) by promoting cholesterol biosynthesis, which further impairs CD8+ T cell function. Here, METTL3 is linked to hepatocellular carcinoma.